In the afternoon of April 17, 2016, Professor Ming-Wei Wang, Dean, School of Pharmacy, Fudan University and Director of the National Center for Drug Screening/Chinese National Compound Library met with Dr. Henry (Hongjun) Ji, a renowned biotechnology entrepreneur and Chief Executive Officer of Sorrento Therapeutics, Inc. (NASDAQ: SRNE). They discussed in detail regarding the proposition and plan of launching multilateral transpacific research collaborations on therapeutic antibodies.